Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.

doi:10.1016/0014-5793(95)01063-k

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.

FEBS letters - 16 Oct 1995

Chao C C

Abstract excerpt

A multidrug-resistant (MDR) subline of the immunoblastic B lymphoma cell line was established by sequentially selecting in increasing concentrations of adriamycin. The adriamycin-resistant cell line (HOB1/ADR) demonstrated resistance to a wide spectrum of chemotherapeutic agents including MDR dru...

Topics

ATP Binding Cassette Transporter, Subfamily B, Member 1
Antineoplastic Agents
Base Sequence
Blotting, Western
Cell Division
Doxorubicin
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Gene Dosage
Gene Expression
Humans
Lymphoma, B-Cell
Molecular Sequence Data
Phenotype
Polymerase Chain Reaction
Precursor Cell Lymphoblastic Leukemia-Lymphoma
RNA, Messenger
Tumor Cells, Cultured

Source

Open in PubMed

Identifiers

PMID: 7589484
DOI: 10.1016/0014-5793(95)01063-k

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-7589484-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics